Life Science Company News

Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market Landscape - Technavio

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Mommy's Heart Hosts Successful Fundraising Event in Richmond, VA

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

A New Era in Medicine: How Antibody Drugs are Revolutionizing Healthcare

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Pulmonary Arterial Hypertension Drugs Market to Grow by USD 2.26 Billion from 2024-2028, as Rising PAH Prevalence Drives Demand with AI Redefining Market Landscape - Technavio

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Global Medical Tapes Market Growth Driven by Aging Population and Healthcare Advances

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Ypsomed and CamDiab receive Health Canada approval for mylife YpsoPump and CamAPS FX, and provide an enhancing diabetes management

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Read more ››
By: PR Newswire Association LLC. - 07 Nov 2024

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

Read more ››
By: GlobeNewswire - 07 Nov 2024

PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

Read more ››
By: GlobeNewswire - 07 Nov 2024

Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS

Read more ››
By: GlobeNewswire - 07 Nov 2024

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting

Read more ››
By: GlobeNewswire - 07 Nov 2024

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Read more ››
By: GlobeNewswire - 07 Nov 2024

IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study

Read more ››
By: GlobeNewswire - 07 Nov 2024

Aummune Announces Results from Phase 1 Trial of its Novel AM003 Immunotherapy for the Treatment of Solid Tumors

Read more ››
By: GlobeNewswire - 07 Nov 2024

Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy a

Read more ››
By: GlobeNewswire - 07 Nov 2024

Growth in revenue and operating profit

Read more ››
By: GlobeNewswire - 07 Nov 2024

Ramsay Sante : Q1 results as of September 30, 2024

Read more ››
By: GlobeNewswire - 07 Nov 2024

Safe out of receivership

Read more ››
By: GlobeNewswire - 07 Nov 2024

Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Read more ››
By: GlobeNewswire - 07 Nov 2024
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate